ImportRefusal LogoImportRefusal

GlaxoSmith Kline

⚠️ High Risk

FEI: 3005404124 • Nashik, Maharashtra • INDIA

FEI

FEI Number

3005404124

📍

Location

Nashik, Maharashtra

🇮🇳

Country

INDIA
🏢

Address

A - 10 Midc Ambad - Pathardi Block, , Nashik, Maharashtra, India

High Risk

FDA Import Risk Assessment

62.8
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

3
Total Refusals
1
Unique Violations
12/18/2025
Latest Refusal
4/24/2017
Earliest Refusal

Score Breakdown

Violation Severity
90.0×40%
Refusal Volume
22.3×30%
Recency
98.6×20%
Frequency
3.5×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

753×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
12/18/2025
61GDY81MUPIROCIN (ANTI-BACTERIAL, PART II) (NOT ANTIBIOTIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/1/2025
61WDY04CLOTRIMAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
4/24/2017
60WCA12DIETHYLCARBAMAZINE CITRATE (ANTHELMINTIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is GlaxoSmith Kline's FDA import refusal history?

GlaxoSmith Kline (FEI: 3005404124) has 3 FDA import refusal record(s) in our database, spanning from 4/24/2017 to 12/18/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. GlaxoSmith Kline's FEI number is 3005404124.

What types of violations has GlaxoSmith Kline received?

GlaxoSmith Kline has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about GlaxoSmith Kline come from?

All FDA import refusal data for GlaxoSmith Kline is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.